Melbourne, Australia

Harry Unger

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Polypharma Pty Ltd. Active years: 2019.

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Harry Unger - Innovator in Delivery Systems

Introduction

Harry Unger is an accomplished inventor based in Melbourne, Australia. He has made significant contributions to the field of delivery systems, particularly through his innovative patent. His work focuses on the efficient transport of molecules and nanoparticles, which has potential applications in various industries.

Latest Patents

Harry Unger holds a patent for a delivery system and process. This system includes a material designed for storing molecules and/or nanoparticles by binding them to the material. It also features a means for applying an electric field to release these molecules and/or nanoparticles, as well as a means for applying an ultrasonic signal to transport them through the material to a surface for delivery to an entity. This patent showcases his ingenuity and commitment to advancing technology in this area.

Career Highlights

Unger is currently associated with Polypharma Pty Ltd, where he continues to develop and refine his innovative ideas. His career is marked by a dedication to research and development, contributing to advancements in delivery systems that can enhance various applications.

Collaborations

Harry has worked alongside notable colleagues, including Mark Unger and Donald Martin. Their collaborative efforts have further enriched the research environment and fostered innovation within their projects.

Conclusion

In summary, Harry Unger is a notable inventor whose work in delivery systems has the potential to impact multiple fields. His patent reflects a significant advancement in the efficient transport of molecules and nanoparticles. His contributions to Polypharma Pty Ltd and collaborations with other professionals highlight his commitment to innovation and excellence in his field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…